Comprehensive Urologic Care

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Bladder cancer1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Sumitomo Pharma America, Inc.2 trials
• ORIC Pharmaceuticals1 trial
• Protara Therapeutics1 trial

Running trials

• Recruiting

  Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  NCT05951179· Phase 2· Protara Therapeutics· Source

  Contact: Chief Scientific Operations Officer

• Recruiting

  Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  NCT05413421· Phase 1· ORIC Pharmaceuticals· Source

  Contact: ORIC Clinical

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

  NCT05605964· Phase 3· Sumitomo Pharma America, Inc.· Source

• Completed

  A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

  NCT05467176· Sumitomo Pharma America, Inc.· Source